Abstract
The factor p8 is a high mobility group (HMG) A family member that is upregulated during the cellular stress response in numerous tissues. Because expression of this protein encourages cellular transformation, our goal is to characterize the mechanism by which the p8 gene is regulated. Using LßT2 cells as a model of a transformed cell in which p8 plays a role in tumor formation, we dissected the p8 promoter into its minimal functional units and found that activating transcription factor 4 (ATF4), a factor also upregulated during cellular stress responses, enhances p8 promoter activity in a dose-dependent manner. In addition, ATF4 binds in the highly conserved major activation domain of the p8 proximal promoter between-130 and-100 bp. Furthermore, we show that six of the nine base pairs that encompass the putative element are essential for ATF4 binding. These findings increase our know ledge of the mechanisms regulating the p8 gene in a genetically defined tumor model.
Similar content being viewed by others
References
Quirk, C.C., Seachrist, D. D., and Nilson, J. H. (2003). J. Biol. Chem. 278, 1680–1685.
Mohammad, H. P., Seachrist, D. D., Quirk, C. C., and Nilson, J. H. (2004), Mol. Endocrinol. 18, 2583–2593.
Mallo, G. V., Fiedler, F., Calvo, E. L. et al (1997). J. Biol. Chem., 272, 32360–32369.
Encinar, J. A., Mallo, G. V., Mizyrycki, C. (et al. (2001), J. Biol. Chem. 276, 2742–2751.
Liu, F., Chau, K. Y., Arlotta, P., and Ono, S. J. (2001), Immunol. Res. 24, 13–29.
Garcia-Montero, A., Vasseur, S., Mallo, G. V., Soubeyran, P., Dagorn, J. C., and Iovanna, J. L. (2001) Eur. J. Cell. Biol. 80, 720–725.
Motoo, Y., Iovanna, J. L., Mallo, G. V., Su, S. B., Xie, M. J. and Sawabu, N., (2001) Dig. Dis. Sci. 46, 1640–1646.
Jiang, Y. F., Vaccaro, M. I., Fiedler, F., Calvo, E. L., and Iovanna, J. L. (1999) Biochem. Biophys. Res. Commun. 260, 686–690.
Reeves, R. (2000). Environ. Health Perspect, 108 (Suppl 5), 803–809.
Reeves, R., (2001). Gene 277, 63–81.
Reeves, R., Edberg, D. D., and Li, Y. (2001). Mol. Cell. Biol. 21, 575–594.
Goruppi, S., Bonventre, J. V., and Kyriakis, J. M. (2002) EMBO J. 21, 5427–5436.
Plant, S. R., Wang, Y., Vasseur, S. et al. (2005). Glia. 53, 529–537.
Ree, A. H., Tvermyr, M., Engebraaten, O., et al. (1999). Cancer Res., 59, 4675–4680.
Ito, Y., Yoshida, H., Motoo, Y., et al. (2005) Anticancer Res. 25, 833–837.
Su, S. B., Motoo, Y., Iovanna, J. L., et al. (2001). Clin. Cancer Res. 7, 1320–1324.
Su, S. B., Motoo, Y., Iovanna, J. L., et al. (2001). Clin. Cancer Res., 7, 309–313.
Ito, Y., Yoshida, H., Motoo, Y., et al. (2003) Cancer Lett. 201, 237–244.
Yamashita S., Wakazono, K., Nomoto, T., Tsujino, Y., Kuramoto, T., and Ushijima, T. (2005). Genetics 171, 1231–1238.
Iovanna, J. L. (2002) Int. J. Gastrointest. Cancer 31, 89–98.
Vasseur, S., Hoffmeister, A., Garcia, S., Bagnis, C., Dagorn, J. C., and Iovanna, J. L. (2002). EMBO Rep. 3, 165–170.
Vasseur, S., Hoffmeister, A., Garcia-Montero, A., et al. (2002). Oncogene 21, 1685–1694.
Malicet, C., Hoffmeister, A., Moreno, S., et al. (2006). Biochem. Biophys. Res. Commun. 339, 284–289.
Malicet, C., Giroux, V., Vasseur, S., Dagorn, J. C., Neira, J. L. and Iovanna, J. L. (2006). Proc. Natl. Acad. Sci. USA 103, 2671–2676.
Tanaka, T., Tsujimura, T., Takeda, K., et al. (1998). Genes Cells 3, 801–810.
Hewes, R. S., Schaefer, A. M., and Taghert, P. H. (2000). Genetics 155, 1711–1723.
Bagheri-Yamanand, R., Vadlamudi, R. K., and Kumar, R. (2003). J. Biol. Chem. 278, 1742–17429.
Fischer, C., Johnson, J., Stillwell, B., et al. (2004). Biol. Reprod. 70, 371–378.
Ritter, B., Zschuntsch, J., Kvachnina, E., Zhang, W., and Ponimaskin, E. G. (2004), Brain Res. Dev. Brain Res. 149, 73–77.
Yang, X., Matsuda, K., Bialek, P, et al. (2004). Cell, 117, 387–398.
Rutkowski, D. T. and Kaufman, R. J. (2003). Dev. Cell 4, 442–444.
Harding, H. P., Novoa, I., Zhang, Y., et al. (2000). Mol. Cell 6, 1099–1108.
Harding, H. P., Zhang, Y., Zeng, H., et al. (2003), Mol. Cell. 11, 619–633
Blais, J. D., Filipenko, V., Bi, M., et al. (2004). Mol. Cell. Biol. 24, 7469–7482.
Jean, S., Bideau, C., Bellon, L., et al. (2001). Biochim. Biophys. Acta 1522, 89–96.
Roybal, C. N., Yang, S., Sun, C. W., et al (2004), J. Biol. Chem. 279, 14844–14852.
Quandt, K., Frech, K., Karas, H., Wingender, E., and Werner, T. (1995). Nucleic Acids. Res. 23, 4878–4884.
Johnson, P. F. (1993). Mol. Cell. Biol., 13, 6919–6930.
Haas, N. B., Cantwell, C. A., Johnson, P. F., and Burch, J. B. (1995). Mol. Cell. Biol. 15, 1923–1932.
Gachon, F., Fonjallaz, P., Damiola, F., et al. (2004). Genes Dev. 18, 1397–1412.
Heaney, A. P., Fernando, M., and Melmed, S. (2003). J. Clin. Invest. 111, 1381–1388.
Lu, P. D., Harding, H. P., and Ron, D. (2004). J. Cell. Biol. 167, 27–33.
Vattem, K. M. and Wek, R. C. (2004). Proc. Natl. Acad. Sci. USA 101, 11269–11274.
Carracedo, A., Egia, A., Guzman, M., and Velasco, G. (2006). FEBS Lett. 580, 1571–1575.
Carracedo, A., Lorente, M., Egia, A., et al. (2006). Cancer Cell 9, 301–312.
Vasseur, S., Mallo, G. V., Garcia-Montero, A., et al. (1999). Biochem. J., 343, (Pt 2), 377–383.
Okamoto, A., Iwamoto, Y., and Maru, Y. (2006). Mol. Cell. Biol. 26, 1087–1097.
Quirk, C. C., Lozada, K. L., Keri, R. A., and Nilson, J. H. (2001). Mol. Endocrinol. 15, 734–746.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Passe, C.M.M., Cooper, G. & Quirk, C.C. The murine p8 gene promoter is activated by activating transcription factor 4 (ATF4) in the gonadotrope-derived L\T2 cell line. Endocr 30, 81–91 (2006). https://doi.org/10.1385/ENDO:30:1:81
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:30:1:81